Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Minimal Residual Disease + B-Cell Acute Lymphoblastic Leukemia”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Early research (Phase 1)Active Not RecruitingNCT03233854
What this trial is testing

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies

Who this might be right for
B Acute Lymphoblastic LeukemiaCD19 PositiveMinimal Residual Disease+1 more
Stanford University 56
Not applicableUnknownNCT03413046
What this trial is testing

The Effect of Chemotherapy on Regulatory T Cells

Who this might be right for
Pre B ALLRegulatory T Cell
Ankara Children's Health and Diseases Hematology and Oncology Training and Research Hospital 60
Not applicableUnknownNCT05837689
What this trial is testing

Minimal Residual Disease Quantification by Next-generation Sequencing in Pediatric B-ALL Children Patients Treated With Blinatumomab Consolidation

Who this might be right for
Acute Lymphoblastic Leukemia, Pediatric
Xiaojun Xu 20
Testing effectiveness (Phase 2)Ended earlyNCT04044560
What this trial is testing

Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant

Who this might be right for
B-cell Adult Acute Lymphoblastic LeukemiaStem Cell LeukemiaMinimal Residual Disease
University of British Columbia 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT03610438
What this trial is testing

Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 76
Not applicableStudy completedNCT02010931
What this trial is testing

Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Amgen 310
Testing effectiveness (Phase 2)Study completedNCT03096782
What this trial is testing

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Leukemia+19 more
M.D. Anderson Cancer Center 6
Not applicableStudy completedNCT03751072
What this trial is testing

Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO)

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia With Failed Remission
Group for Research in Adult Acute Lymphoblastic Leukemia 92
Testing effectiveness (Phase 2)Study completedNCT03367299
What this trial is testing

Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoid LeukemiaPhiladelphia Chromosome-Negative B-Cell Precursor
Gruppo Italiano Malattie EMatologiche dell'Adulto 149
Large-scale testing (Phase 3)Looking for participantsNCT07441291
What this trial is testing

CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT

Who this might be right for
B ALLAllogenetic Hematopoietic Stem Cell TransplantationMRD-positive
Peking University People's Hospital 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT07134088
What this trial is testing

Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic LeukemiaMinimal Residual Disease + B-Cell Acute Lymphoblastic Leukemia
Amgen 104
Testing effectiveness (Phase 2)Ended earlyNCT02767934
What this trial is testing

Pembrolizumab in Treating Minimal Residual Disease in Patients With Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic LeukemiaMinimal Residual DiseaseRecurrent Acute Lymphoblastic Leukemia+1 more
University of Washington 12
Testing effectiveness (Phase 2)Looking for participantsNCT05735717
What this trial is testing

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Who this might be right for
Hematologic MalignancyAcute LeukemiaRemission+21 more
Masonic Cancer Center, University of Minnesota 70
Testing effectiveness (Phase 2)Looking for participantsNCT06144606
What this trial is testing

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Who this might be right for
B-Cell Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia
H. Lee Moffitt Cancer Center and Research Institute 60
Testing effectiveness (Phase 2)Looking for participantsNCT06608732
What this trial is testing

Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableNot Yet RecruitingNCT06763302
What this trial is testing

NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL

Who this might be right for
B Cell Precursor Acute Lymphoblastic LeukemiaPediatricMinimal Residual Disease+1 more
The Children's Hospital of Zhejiang University School of Medicine 1,220
Not applicableStudy completedNCT05973032
What this trial is testing

MRD Detection by NGS in Pediatric B-ALL

Who this might be right for
Acute Lymphoblastic Leukemia, Pediatric
The Children's Hospital of Zhejiang University School of Medicine 430
Testing effectiveness (Phase 2)Study completedNCT00458848
What this trial is testing

Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 470
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07192237
What this trial is testing

Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Phase 2 StudyBlinatumomabAcute Lymphoblastic Leukemia
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT07400029
What this trial is testing

Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center 40
Next Page